Retatrutide Generic Timeline: When Will Copies Come?
Do not hold your breath for generic retatrutide -- but affordable access is available today.
When a brand-name drug is expensive, the natural question is: when will a generic be available? For retatrutide, the honest answer is: not for a very long time. Here is why -- and how to access affordable retatrutide right now.
Estimated Generic Timeline
Retatrutide Patent/Generic Timeline
Why Generics Take So Long
- Patent thickets: Lilly will likely have 10-20+ patents covering retatrutide from different angles
- Biologics pathway: Peptide drugs require biosimilar (not generic) pathway -- more complex and expensive
- Data exclusivity: 12 years of data exclusivity for biologics under the BPCIA
- Litigation: Patent challenges result in years of court battles
- Manufacturing complexity: Triple agonist peptides are harder to copy than small-molecule drugs
Affordable Alternatives Today
Waiting 15-20+ years for generic retatrutide is not a realistic option for patients who need weight loss treatment now. Compounding provides legal, affordable access today. Trimi offers semaglutide ($99/mo), tirzepatide ($125/mo), and retatrutide -- all available now, no insurance needed.
Do Not Wait 20 Years
Affordable GLP-1 access is available today through Trimi. Start with semaglutide at $99/month.
Get StartedMedical Disclaimer
Patent and timeline estimates are based on industry analysis and are not guaranteed. Retatrutide is investigational. Consult your healthcare provider.
More on retatrutide
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).